128 related articles for article (PubMed ID: 37029728)
1. Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer.
Chen H; Tian X; Luan Y; Lu H
J Obstet Gynaecol; 2023 Dec; 43(1):2196344. PubMed ID: 37029728
[TBL] [Abstract][Full Text] [Related]
2. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
[TBL] [Abstract][Full Text] [Related]
3. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma.
Kubik S; Jesionek-Kupnicka D; Stawiski K; Fijuth J; Moszynska-Zielinska M; Kuncman L; Pajdzinski M; Gottwald L
J Obstet Gynaecol; 2022 Aug; 42(6):2248-2254. PubMed ID: 35264072
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
Guo Q; Zhu J; Wu Y; Wen H; Xia L; Wu X; Ju X
Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
Rao X; Jiang J; Wang Y; Ma X; Liu S
Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigen combined with HPV-16 infection in predicting high-grade squamous intraepithelial lesions of the cervix.
Zhong G; Wang Y; Yao S; Fang X; Lin R; Lin Z; Peng Y; Yao T
J Obstet Gynaecol; 2022 May; 42(4):696-700. PubMed ID: 34565271
[TBL] [Abstract][Full Text] [Related]
8. CircRNA circ_0005273 contributes to the cisplatin resistance of cervical cancer cells by sponging miR-133b.
Wu L; Gao J; Liu S; Jia Y; Li C; Duan L
J Obstet Gynaecol; 2022 Oct; 42(7):3086-3093. PubMed ID: 35861544
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
11. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
[TBL] [Abstract][Full Text] [Related]
12. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
[TBL] [Abstract][Full Text] [Related]
13. The profile analysis of circular RNAs in cervical cancer.
Huang J; Chen J; Huang Q
Medicine (Baltimore); 2021 Oct; 100(39):e27404. PubMed ID: 34596168
[TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
Salvatici M; Achilarre MT; Sandri MT; Boveri S; Vanna Z; Landoni F
Gynecol Oncol; 2016 Jul; 142(1):115-119. PubMed ID: 27117922
[TBL] [Abstract][Full Text] [Related]
15. PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women.
He L; Luo X; Bu Q; Jin J; Zhou S; He S; Zhang L; Lin Y; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2179916. PubMed ID: 36799003
[TBL] [Abstract][Full Text] [Related]
16. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
18. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
[No Abstract] [Full Text] [Related]
20. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]